DUOPHARMA BIOTECH BERHAD

KLSE (MYR): DPHARMA (7148)

You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!

Last Price

1.21

Today's Change

-0.02 (1.63%)

Day's Change

1.21 - 1.22

Trading Volume

348,300

Financial

T4Q

31-Mar-2021

2020

31-Mar-2021

2019

31-Mar-2021

2018

31-Mar-2021

2017

31-Mar-2021

Total assets

238

-1.64%

1000

+11.55%

110

+81.66%

900

-13.16%

600

+235.36%

Total current assets

238

1000

110

900

600

Cash & equivalents

238

1000

110

900

600

Short term investments

238

1000

110

900

600

Total receivables, net

238

1000

110

900

600

Accounts receivable - trade, net

238

1000

110

900

600

Other receivables

238

1000

110

900

600

Total inventory

238

1000

110

900

600

Inventories - work in progress

238

1000

110

900

600

Inventories - progress payments & other

238

1000

110

900

600

Inventories - finished goods

238

1000

110

900

600

Inventories - raw materials

238

1000

110

900

600

Total non-current assets

238

1000

110

900

600

Long term investments

238

1000

110

900

600

Note receivable - long term

238

1000

110

900

600

Investments in unconsolidated subsidiaries

238

1000

110

900

600

Other investments

238

1000

110

900

600

Net property/plant/equipment

238

1000

110

900

600

Gross property/plant/equipment

238

1000

110

900

600

Accumulated depreciation, total

238

1000

110

900

600

Deferred tax assets

238

1000

110

900

600

Net intangible assets

238

1000

110

900

600

Other current assets, total

238

1000

110

900

600

Total liabilities

238

-1.64%

1000

+11.55%

110

+81.66%

900

-13.16%

600

+235.36%

Total current liabilities

-238

-1000

-110

-900

-600

Total non-current liabilities

-238

-1000

-110

-900

-600

Long term debt

238

1000

110

900

600

Long term debt excl. lease liabilities

238

1000

110

900

600

Capital and operating lease obligations

238

1000

110

900

600

Provision for risks & charge

-238

-1000

-110

-900

-600

Deferred tax liabilities

-238

-1000

-110

-900

-600

Other liabilities, total

-238

-1000

-110

-900

-600

Total equity

-238

-1.64%

-1000

+11.55%

-110

+81.66%

-900

-13.16%

-600

+235.36%

Total liabilities & shareholders' equities

238B

1000B

110B

900B

600B

Total debt

238

1000

110

900

600

Book value per share

-238

-1000

-110

-900

-600

Discussions
13 people like this. Showing 50 of 12,443 comments

midswing

Down the hill...
Potential rebound?

2023-08-18 23:17

chkhooju

Possible.

2023-08-24 13:39

NoTimeToTrade

Quarter results already reflected in the price before the release of the Q2 report

2023-08-25 11:37

fortunefire

good company, can buy more?

2023-08-28 15:00

100Mark

Still a profit-making company. IF got free cash, may be can chip in some

2023-09-04 10:54

100Mark

reaching 52 weeks low, time to grab a bit

2023-09-06 10:28

stevenckheng

noob company slowly moving a way from pharmaceutical

2023-09-06 20:25

teknikal

Support at RM1.10, if broken then RM1 is the next support

2023-09-11 09:17

fortunefire

parking here. tp 0.9x

2023-09-11 11:08

chkhooju

Moving up nicely.

2023-09-11 12:51

BobAxelrod33

Managed and operated by white haired people sitting in wheel chairs and using walking sticks. Most have prostate problems, waking few times at night to urinate. Some are waiting for stairways to Heavens........HOW COULD COMPANY BE AGGRESSIVE???

2023-10-08 13:10

MrFox

fruitcake becimes mouldy!!

2023-11-09 11:38

MagicalBobby

3Q23 profits down 45% YoY....current BOD is a team of silver haired centennials in wheelchairs. Raising 2 Billion bonds for retirement benefits?

BOD too aggressive is bad, weak BOD is also bad.......take your pick.

2023-11-10 12:07

Apastock

mari mari 1.50 yihaa ....

2023-11-10 12:55

BobAxelrod6868

You'd be lucky to even break 1.40.......

2023-11-21 07:47

BobAxelrod33

Pharma is dying, yet this ctnr with Management in wheelchairs cannot take advantage.

2023-12-02 09:04

BobAxelrod33

Max speed 2 mph......take your pick.

2023-12-04 15:13

Jettson8

not yet, it will make good performance in Q4

2023-12-06 16:38

Jettson8

it starts rebounding 😀 up up up

2023-12-15 15:38

NoTimeToTrade

This is just reaction to Covid case spike, after that fall back down. Nothing new and exciting on the horizon for pharma in the coming months especially when Pharmaniaga still in the dump and government cutting back on spending.

2023-12-15 16:03

Liner8

Great upup

2023-12-16 06:54

143922

3.00 is coming

2023-12-16 12:49

Jettson8

Dpharma is more stable and solid than those companies, fruitcake

2023-12-24 09:46

143922

Jual je la sykt GLC ni.epf pun tak mau beli ticket.kannaya

2023-12-31 09:31

Jettson8

Hope this collaboration can bring good revenue to the company for Fy2024 and so on

https://theedgemalaysia.com/node/692365

2024-01-15 17:14

100Mark

See, Kwsp was buying in. I think it can 😄

2024-01-22 17:34

Jettson8

Ya, even TA securities raised its target price to Rm1.47

2024-01-26 15:41

100Mark

Duopharma Biotech Bhd is likely to see a recovery in its consumer healthcare (CHC) segment, while sales to the government sector is also expected to increase in 2024.

https://www.thestar.com.my/business/business-news/2024/01/26/duopharma-earnings-set-to-improve-this-year

2024-01-30 17:36

metaverse

This is my trading call dated 15 Dec 2020. Most of the time chart will tell the true story:

https://www.tradingview.com/chart/DPHARMA/5tKe08jN-Trend-Analysis/


For investment or trading ideas, please feel free to visit my chart gallery:

https://www.tradingview.com/u/Yang358/#published-charts

2024-01-31 17:43

100Mark

@metaverse. What did you use for that technical analysis?

2024-02-02 16:19

metaverse

I love astronomy so most of my calculation/logics actually somehow related to astrophysics and planetary orbit. Something to do with price resistance, time resistance and speed resistance.

2024-02-02 16:45

MrFox

fruitcake turns mouldy?

2024-02-21 11:40

Meshach Mano

Starting its journey to 1.4 soon

2 months ago

cyberzigot

Limit up

2 months ago

Mar2083

Afternoon sessions limit up
Huat ar

2 months ago

NoTimeToTrade

Duopharma Biotech Clinches MYR578 million Supply Deals

https://www.tradingview.com/news/mtnewswires.com:20240501:G2361746:0/

2 months ago

jenabchen123

Yuhoo!!! Finally Duo making big move. 1.40 seems reasonable figure to relief breath.

2 months ago

Mar2083

Potentially may test 1. 4 tomorrow

2 months ago

jenabchen123

Ayo!!! What has 600m contract do to the Duo's share price??? Sometime the illogical happen.....

2 months ago

Jettson8

or you are more fond of pharmaniaga, fruitcake 😁

1 month ago

Jettson8

That is 1-year low price for Dpharma dude

fruitcake

1.10 please

19 hours ago

1 month ago

Jettson8

A+ for your patience 😆

1 month ago

NoTimeToTrade

Haha unfortunately i'm closing my position with Dpharma, feels like watching paint dry. Anyways good luck guys.

3 weeks ago

Jettson8

I am pretty sure you made a good profit from it, NoTimeToTrade 😉

3 weeks ago

100Mark

Oww...EPF is throwing this moth

1 week ago

fruitcake

yup. epf dislike this dummo. not so soon, possible back to 1.20 level

1 week ago

100Mark

EPF switched to another counters like CTOS, KLK, ...

1 week ago

Jettson8

no worries, Duopharma still hanging strong

4 days ago

Post a Comment